Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
Proton pump inhibitors (PPIs) are commonly used to lessen symptoms in patients with gastroesophageal reflux disease (GERD). However, the effects of PPI therapy on the gastrointestinal microbiota in GERD patients remain unclear. We examined the association between the PPI usage and the microbiota pre...
Main Authors: | Yi-Chao Shi, Shun-Tian Cai, Ya-Ping Tian, Hui-Jun Zhao, Yan-Bing Zhang, Jing Chen, Rong-Rong Ren, Xi Luo, Li-Hua Peng, Gang Sun, Yun-Sheng Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-02-01
|
Series: | Genomics, Proteomics & Bioinformatics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1672022919300658 |
Similar Items
-
Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
by: Yichao Shi, et al.
Published: (2023-08-01) -
Options for optimizing treatment of gastroesophageal reflux disease with proton pump inhibitors
by: M. F. Osipenko, et al.
Published: (2015-12-01) -
Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review
by: Mousalreza Hosseini, et al.
Published: (2017-06-01) -
How to Make the Right Choice of Proton Pump Inhibitor for Patients with Gastroesophageal Reflux Disease?
by: Yu. V. Evsyutina
Published: (2023-06-01) -
Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis
by: Toshihiro Nishizawa, et al.
Published: (2020-08-01)